Jane Street’s Mangoceuticals MGRX Stock Holding History

Jane Street’s Portfolio MGRX Stock Details MGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-72,746	Closed	-$26.2K	–	12534
2026 Q1	$26.2K	Buy	72,746 +25,243	+53%	+$12.1K	﹤0.01%	11143
2025 Q4	$35.2K	Buy	+47,503	New	+$77K	﹤0.01%	10605

Other funds holding MGRX

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ACA

Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street's MGRX Position: Q2 2026 in Review

Jane Street sold out of Mangoceuticals (MGRX) in Q2 2026, closing a stake of 72,746 shares — an estimated $26.2K sold.

Jane Street first reported a position in MGRX in Q4 2025 and held it in 2 quarters. The position peaked at $35.2K in Q4 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

Jane Street reported no remaining Mangoceuticals position as of Q2 2026 after selling out during the quarter.
Jane Street sold 72,746 Mangoceuticals shares in Q2 2026, an estimated $26.2K.
Jane Street first reported a position in Mangoceuticals in Q4 2025 and held it in 2 quarters.
Jane Street's Mangoceuticals position peaked at $35.2K in Q4 2025.
18 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.